We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · June 26, 2020

ctDNA Markers of Progression in Advanced Breast Cancer Treated With Fulvestrant With or Without Palbociclib

Journal of the National Cancer Institute

 

Additional Info

Journal of the National Cancer Institute
Circulating Tumor DNA Markers for Early Progression on Fulvestrant With or Without Palbociclib in ER+ Advanced Breast Cancer
J. Natl. Cancer Inst 2020 Jun 17;[EPub Ahead of Print], B O’Leary, RJ Cutts, X Huang, et al

Further Reading